HomeTagsPolymer Drug Delivery Prostheses

Polymer Drug Delivery Prostheses

CorMatrix Cardiovascular Receives European Community and U.S. Patent Claim Allowances for Polymer Drug Delivery Prostheses

The European and U.S. Patent allowances will further enhance CorMatrix's growing synthetic polymer and ECM (Extracellular Matrix) delivery platforms, which, in addition to PGS, includes poly(urethane urea), polylactide (PLA), poly(e-caprolactone) (PCL) and polyglycolide (PLGA) compositions and structures.

By using this website you agree to accept Medical Device News Magazine Privacy Policy

Exit mobile version